|
76
|
301
|
9riyA |
Sars-cov-2 with a bound inhibitor |
|
77
|
301
|
9rixA |
Sars-cov-2 with a bound inhibitor |
|
82
|
306
|
9rj0A |
Sars-cov-2 with a bound inhibitor |
|
81
|
306
|
9ri3A |
Sars-cov-2 with a bound inhibitor |
|
79
|
303
|
9rj8A |
Sars-cov-2 with a bound inhibitor |
|
79
|
301
|
9rizA |
Sars-cov-2 with a bound inhibitor |
|
88
|
306
|
9rj3A |
Sars-cov-2 with a bound inhibitor |
|
78
|
301
|
9rj7A |
Sars-cov-2 with a bound inhibitor |
|
89
|
301
|
9ridA |
Sars-cov-2 with a bound inhibitor |
|
78
|
301
|
9rjfA |
Sars-cov-2 with a bound inhibitor |
|
76
|
301
|
9rj5A |
Sars-cov-2 with a bound inhibitor |
|
75
|
301
|
9rhsA |
Structure of 3cl protease with a bound inhibitor |
|
79
|
306
|
9ri1A |
Sars-cov-2 with a bound inhibitor |
|
75
|
301
|
9rjrA |
Sars-cov-2 with a bound inhibitor |
|
31
|
107
|
9pysA |
Nmr rdc refinement of the helical domain of the sars-cov-2 monomeric main protease (mproh41q,10-306) |
|
82
|
305
|
9pfiA |
Crystal structure of sars-cov-2 mpro mutant p132h |
|
77
|
300
|
9pfhA |
Crystal structure of sars-cov-2 mpro mutant p132h with c5a |
|
36
|
175
|
9pytA |
Nmr rdc refinement of the catalytic domain of the sars-cov-2 monomeric main protease (mproh41q,10-306) |
|
89
|
306
|
9nskA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with inhibitor bbh-3 |
|
86
|
306
|
9nslA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with with inhibitor bbh-4 |
|
88
|
305
|
9n6nA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with pomotrelvir |
|
89
|
302
|
9n6rA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with ensitrelvir |
|
88
|
301
|
9n6pA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with ensitrelvir |
|
88
|
305
|
9n6jA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion |
|
83
|
305
|
9n6mA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with nirmatrelvir |
|
84
|
305
|
9n6lA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with gc373 |
|
87
|
301
|
9mvqA |
Crystal structure of sars-cov-2 main protease (mpro) variant q192t in complex with inhibitor avi-4303 |
|
91
|
305
|
9mvoA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with inhibitor avi-4692 |
|
77
|
305
|
9mvpA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-4516 |
|
85
|
301
|
9mdqA |
Crystal structure of sars-cov-2 omicron main protease (mpro) complex with azapeptide inhibitor 20a |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
83
|
302
|
9kgsA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
79
|
298
|
9kgjA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
92
|
307
|
9kgrA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
88
|
300
|
9j8tA |
Crystal structure of sars-cov-2 main protease in complex with mp-4l2 |
|
82
|
301
|
9j8uA |
Crystal structure of sars-cov-2 main protease in complex with mp-4d7 |
|
0
|
14
|
9j8uC |
Crystal structure of sars-cov-2 main protease in complex with mp-4d7 |
|
84
|
304
|
9hfxA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097558 |
|
87
|
303
|
9hfyA |
Crystal structure of sars cov-2 3clpro (mpro) with alg-097078 |
|
88
|
306
|
9ghnA |
Structure of sars-cov-2 main protease (mpro) with mutation of q256a |
|
79
|
305
|
9ghoA |
Structure of sars-cov-2 main protease (mpro) with mutation of s284a |
|
83
|
302
|
9g0hA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17a |
|
83
|
302
|
9g0iA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the noncovalently bound inhibitor c5n17b |
|
88
|
301
|
9ddfA |
Sars-cov-2 main protease with inhibitor |
|
89
|
302
|
9ddgA |
Sars-cov-2 main protease with inhibitor |
|
83
|
301
|
9cjtA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with bofutrelvir |
|
83
|
303
|
9cjvA |
X-ray crystal structure of sars-cov-2 main protease complex with bofutrelvir |
|
83
|
303
|
9cjpA |
X-ray crystal structure of sars-cov-2 main protease quadruple mutants in complex with nirmatrelvir |
